CITY THERAPEUTICS, INC. ($CTY)
Filing Information
| Accession Number | 0001104659-26-116966 |
|---|---|
| Form Type | 4 |
| Filing Date | Oct 19, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
20,811,433
Total Value
$3,060,000.00
P&L
+19.2% (+$588,200.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
10% Owner | Common Stock | โ | Oct 19, 2026 | Conversion | 3,294,900 | โ | โ | 6,013,192 | Indirect | By ARCH Venture Fund XII, L.P. | View Details | |
10% Owner | Common Stock | โ | Oct 19, 2026 | Conversion | 5,482,309 | โ | โ | 11,495,501 | Indirect | By ARCH Venture Fund XII, L.P. | View Details | |
10% Owner | Common Stock | โ | Oct 19, 2026 | Conversion | 2,027,006 | โ | โ | 13,522,507 | Indirect | By ARCH Venture Fund XII, L.P. | View Details | |
10% Owner | Common Stock | โ | Oct 19, 2026 | Purchase | 170,000 | $18.00 | $3,060,000.00 | 13,692,507 | Indirect | By ARCH Venture Fund XII, L.P. | View Details | |
10% Owner | Series Seed convertible preferred stock | Derivative | Oct 19, 2026 | Conversion | 3,000,000 | $0.00 | $0.00 | 0 | Indirect | By ARCH Venture Fund XII, L.P. | View Details | |
10% Owner | Series A convertible preferred stock | Derivative | Oct 19, 2026 | Conversion | 4,991,633 | $0.00 | $0.00 | 0 | Indirect | By ARCH Venture Fund XII, L.P. | View Details | |
10% Owner | Series B convertible preferred stock | Derivative | Oct 19, 2026 | Conversion | 1,845,585 | $0.00 | $0.00 | 0 | Indirect | By ARCH Venture Fund XII, L.P. | View Details |